Is 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide? Is 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide safe for nursing mother and child? Does 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide extracts into breast milk? Does 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide has any long term or short term side effects on infants? Can 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide influence milk supply or can 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide decrease milk supply in lactating mothers?
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide lactation summary
- DrLact safety Score for 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide .
- Usage of 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide is in contradiction to breastfeeding hence if it is must to use 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide usage in lactation
We are working on a comment for this product.
Answer by DrLact: About 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide usage in lactation
No information is available on the use of 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide during breastfeeding, so an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1][2]
Alternate Drugs
Auranofin(Low Risk)
Certolizumab Pegol(Safe)
Adalimumab(Safe)
Methotrexate(Low Risk)
Infliximab(Safe)
Leflunomide(Dangerous)
Sulfasalazine(Safe)
Tocilizumab(Low Risk)
Hydroxychloroquine(Safe)
Chloroquine(Safe)
Anakinra(Low Risk)
Abatacept(Low Risk)
Penicillamine(Low Risk)
Rituximab(Low Risk)
Etanercept(Safe)
Pimecrolimus(Low Risk)
Methotrexate(Low Risk)
Everolimus(Unsafe)
Leflunomide(Dangerous)
Fluorouracil(Dangerous)
Tacrolimus(Safe)
Alemtuzumab(Low Risk)
Mercaptopurine(Safe)
Gemcitabine(Dangerous)
Fingolimod(Unsafe)
Sirolimus(Unsafe)
Cladribine(Dangerous)
Cyclosporine(Safe)
Dimethyl fumarate(Low Risk)
Azathioprine(Safe)